Following The Lancet’s publication of research showing that the Sputnik V vaccine had efficacy of 91.6 percent in clinical trials, Kirill Dmitriev, the director of the investment fund behind Russia’s COVID jab, speaks to RT, stressing the need for equitable vaccine access.
‘Lancet driven by science, not politics’ – Head of Russian Direct Investment Fund
